Acetylsalicylic acid (aspirin) reduces damage to reconstituted human tissues infected with Candida species by inhibiting extracellular fungal lipases

Microbes and Infection

Volumn 11, Issue 14-15, 2009, Pages 1131-1139

  Trofa, David ^a   Agovino, Mariangela ^a   Stehr, Frank ^b   Schäfer, Wilhelm ^b   Rykunov, Dmitry ^a   Fiser, András ^a   Hamari, Zsuzsanna ^c   Nosanchuk, Joshua D ^a   Gácser, Attila ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF HAMBURG   (Germany)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acetylsalicylic acid; Candida; Human fungal pathogen; Inhibition; Lipases; Pathogenesis; Yeast

Indexed keywords

ACETYLSALICYLIC ACID; EBELACTONE B; ESTERASE INHIBITOR; OLIVE OIL; QUININE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA ANTARCTICA; CANDIDA CYLINDRACEA; CANDIDA PARAPSILOSIS; CANDIDIASIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENZYME INHIBITION; ENZYME STRUCTURE; FUNGUS CULTURE; HUMAN; HUMAN TISSUE; LIPOLYSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

ASPIRIN; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CELL LINE, TUMOR; CELLS, CULTURED; EPITHELIUM; FUNGAL PROTEINS; HUMANS; LIPASE; MOUTH;

CANDIDA; CANDIDA ALBICANS; CANDIDA ANTARCTICA; CANDIDA CYLINDRACEA; CANDIDA PARAPSILOSIS; FUNGI;

EID: 71649104743     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.08.007     Document Type: Article

References (30)

1. Trofa D., Gacser A., and Nosanchuk J.D. Candida parapsilosis, an emerging fungal pathogen. Clinical Microbiology Reviews 21 (2008) 606-625
2. Gacser A., Trofa D., Schafer W., and Nosanchuk J.D. Targeted gene deletion in Candida parapsilosis demonstrates the role of secreted lipase in virulence. Journal of Clinical Investigation (2007)
3. Gacser A., Schafer W., Nosanchuk J.S., Salomon S., and Nosanchuk J.D. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genetics and Biology (2007)
4. Korting H.C., Patzak U., Schaller M., and Maibach H.I. A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatment. The Journal of Infection 36 (1998) 259-267
5. Schaller M., Korting H.C., Schafer W., Bastert J., Chen W., and Hube B. Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis. Molecular Microbiology 34 (1999) 169-180
6. Schmid R.D., and Verger R. Lipases: interfacial enzymes with attractive applications. Angewandte Chemie International Edition 37 (1998) 1608-1633
7. Uppenberg J., Ohrner N., Norin M., Hult K., Kleywegt G.J., Patkar S., Waagen V., Anthonsen T., and Jones T.A. Crystallographic and molecular-modeling studies of lipase B from Candida antarctica reveal a stereospecificity pocket for secondary alcohols. Biochemistry 34 (1995) 16838-16851
8. Bramono K., Yamazaki M., Tsuboi R., and Ogawa H. Comparison of proteinase, lipase and alpha-glucosidase activities from the clinical isolates of Candida species. Japanese Journal of Infectious Diseases 59 (2006) 73-76
9. Gacser A., Stehr F., Kroger C., Kredics L., Schafer W., and Nosanchuk J.D. Lipase 8 affects the pathogenesis of Candida albicans. Infection and Immunity (2007)
10. Stehr F., Felk A., Gacser A., Kretschmar M., Mahnss B., Neuber K., Hube B., and Schafer W. Expression analysis of the Candida albicans lipase gene family during experimental infections and in patient samples. FEMS Yeast Research 4 (2004) 401-408
11. Schaller M., Borelli C., Korting H.C., and Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48 (2005) 365-377
12. Vane J.R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology 231 (1971) 232-235
13. Meade E.A., Smith W.L., and DeWitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. Journal of Biological Chemistry 268 (1993) 6610-6614
14. Roth G.J., Stanford N., and Majerus P.W. Acetylation of prostaglandin synthase by aspirin. Proceedings of the National Academy of Sciences of the United States of America 72 (1975) 3073-3076
15. Lecomte M., Laneuville O., Ji C., DeWitt D.L., and Smith W.L. Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin. Journal of Biological Chemistry 269 (1994) 13207-13215
16. Deva R., Ciccoli R., Kock L., and Nigam S. Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis. FEMS Microbiology Letters 198 (2001) 37-43
17. Alem M.A., and Douglas L.J. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrobial Agents and Chemotherapy 48 (2004) 41-47
18. Stepanovic S., Vukovic D., Jesic M., and Ranin L. Influence of acetylsalicylic acid (aspirin) on biofilm production by Candida species. Florence, Italy. Journal of Chemotherapy 16 (2004) 134-138
19. Catterall M.D., Ward M.E., and Jacobs P. A reappraisal of the role of pityrosporum orbiculare in pityriasis versicolor and the significance of extracellular lipase. The Journal of Investigative Dermatology 71 (1978) 398-401
20. Finn R.D., Mistry J., Schuster-Bockler B., Griffiths-Jones S., Hollich V., Lassmann T., Moxon S., Marshall M., Khanna A., Durbin R., Eddy S.R., Sonnhammer E.L., and Bateman A. Pfam: clans, web tools and services. Nucleic Acids Research 34 (2006) D247-251
21. Berman H.M., Westbrook J., Feng Z., Gilliland G., Bhat T.N., Weissig H., Shindyalov I.N., and Bourne P.E. The protein data bank. Nucleic Acids Research 28 (2000) 235-242
22. Benson D.A., Boguski M.S., Lipman D.J., Ostell J., Ouellette B.F., Rapp B.A., and Wheeler D.L. GenBank. Nucleic Acids Research 27 (1999) 12-17
23. Hube B., and Naglik J. Candida albicans proteinases: resolving the mystery of a gene family. Reading, England. Microbiology 147 (2001) 1997-2005
24. Jaeger K.E., Ransac S., Dijkstra B.W., Colson C., van Heuvel M., and Misset O. Bacterial lipases. FEMS Microbiology Reviews 15 (1994) 29-63
25. Leeuw N.J., Swart C.W., Ncango D.M., Pohl C.H., Sebolai O.M., Strauss C.J., Botes P.J., van Wyk P.W., Nigam S., and Kock J.L. Acetylsalicylic acid as antifungal in eremothecium and other yeasts. Antonie Van Leeuwenhoek 91 (2007) 393-405
26. Sommariva D., Bonfiglioli D., Zanaboni L., and Fasoli A. Effects of acetylsalicylic acid on plasma lipids and on post-heparin lipase activities. International Journal of Clinical Pharmacology Therapy and Toxicology 19 (1981) 112-116
27. Blache D., Bouthillier D., and Davignon J. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis 93 (1992) 179-188
28. Weibel E.K., Hadvary P., Hochuli E., Kupfer E., and Lengsfeld H. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. The Journal of Antibiotics 40 (1987) 1081-1085
29. Gillum A.M., Tsay E.Y., and Kirsch D.R. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Molecular and General Genetics 198 (1984) 179-182
30. Gacser A., Salomon S., and Schafer W. Direct transformation of a clinical isolate of Candida parapsilosis using a dominant selection marker. FEMS Microbiology Letters 245 (2005) 117-121